The authors examined The National Cancer Database for patients who refused recommended surgery and elected stereotactic body radiation therapy (SBRT) for stage I/II non-small cell lung cancer.
You are here:
Survival of Primary Stereotactic Body Radiation Therapy Compared With Surgery for Operable Stage I/II Non-small Cell Lung Cancer
Submitted by: Emily Robinson
Source: The Annals of Thoracic Surgery
Source URL: https://doi.org/10.1016/j.athoracsur.2020.01.073
Keywords:
Author(s): Rhami Khorfan, Timothy J. Kruser, Julia M. Coughlin, Ankit Bharat, Karl Y. Bilimoria, David D. Odell
